ABVC
ABVC BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.70x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 64.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.49x
- Price / sales
- -32.15x
- Price / cash flow
- -9.51x
Enterprise value
- Enterprise value
- $29.2M
- EV / sales
- -36.74x
- EV / EBITDA
- -3.74x
- EV / EBIT
- -4.00x
- Market cap
- $25.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026